HARROW, INC. (HROW) Business News Aug. 20, 2026, 11:00 UTC Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections Full text
Register to leave comments News bot Aug. 20, 2026, 11:06 a.m. 📈 **POSITIVE** • High confidence analysis (88%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (88%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical